152 related articles for article (PubMed ID: 10781435)
1. Sodium nitroprusside augments human lung fibroblast collagen gel contraction independently of NO-cGMP pathway.
Liu XD; Skold CM; Umino T; Spurzem JR; Romberger DJ; Rennard SI
Am J Physiol Lung Cell Mol Physiol; 2000 May; 278(5):L1032-8. PubMed ID: 10781435
[TBL] [Abstract][Full Text] [Related]
2. Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways.
Zhu YK; Liu XD; Sköld MC; Umino T; Wang H; Romberger DJ; Spurzem JR; Kohyama T; Wen FQ; Rennard SI
Am J Respir Cell Mol Biol; 2001 Aug; 25(2):245-53. PubMed ID: 11509336
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide: a trigger for classic preconditioning?
Lochner A; Marais E; Genade S; Moolman JA
Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2752-65. PubMed ID: 11087230
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
7. Carbachol inhibits Na(+)-K(+)-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway.
Ellis DZ; Nathanson JA; Sweadner KJ
Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1685-93. PubMed ID: 11078682
[TBL] [Abstract][Full Text] [Related]
8. Effect of NO donors on protein phosphorylation in intact vascular and nonvascular smooth muscles.
Hennan JK; Diamond J
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1565-80. PubMed ID: 11247767
[TBL] [Abstract][Full Text] [Related]
9. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.
Wong D; Dorovini-Zis K; Vincent SR
Exp Neurol; 2004 Dec; 190(2):446-55. PubMed ID: 15530883
[TBL] [Abstract][Full Text] [Related]
10. Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components.
Yao J; Schoecklmann HO; Pröls F; Gauer S; Sterzel RB
Kidney Int; 1998 Mar; 53(3):598-608. PubMed ID: 9507204
[TBL] [Abstract][Full Text] [Related]
11. Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP.
Sanchez JJ; Abreu P; Gonzalez MC
Eur J Pharmacol; 2002 Mar; 438(1-2):79-83. PubMed ID: 11906714
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide contracts longitudinal smooth muscle of opossum oesophagus via excitation-contraction coupling.
Zhang Y; Paterson WG
J Physiol; 2001 Oct; 536(Pt 1):133-40. PubMed ID: 11579163
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway.
Kalra D; Baumgarten G; Dibbs Z; Seta Y; Sivasubramanian N; Mann DL
Circulation; 2000 Sep; 102(11):1302-7. PubMed ID: 10982547
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
16. Cardiac mitochondrial cGMP stimulates cytochrome c release.
Seya K; Motomura S; Furukawa K
Clin Sci (Lond); 2007 Jan; 112(2):113-21. PubMed ID: 16961461
[TBL] [Abstract][Full Text] [Related]
17. Effect of nitric oxide-cGMP-dependent protein kinase activation on advanced glycation end-product-induced proliferation in renal fibroblasts.
Huang JS; Chuang LY; Guh JY; Chen CJ; Yang YL; Chiang TA; Hung MY; Liao TN
J Am Soc Nephrol; 2005 Aug; 16(8):2318-29. PubMed ID: 15958724
[TBL] [Abstract][Full Text] [Related]
18. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
Antonova GN; Snead CM; Antonov AS; Dimitropoulou C; Venema RC; Catravas JD
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H893-903. PubMed ID: 17012359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
